Literature DB >> 22218969

Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011.

Hisanori Umehara1, Kazuichi Okazaki, Yasufumi Masaki, Mitsuhiro Kawano, Motohisa Yamamoto, Takako Saeki, Shoko Matsui, Tadashi Yoshino, Shigeo Nakamura, Shigeyuki Kawa, Hideaki Hamano, Terumi Kamisawa, Toru Shimosegawa, Akira Shimatsu, Seiji Nakamura, Tetsuhide Ito, Kenji Notohara, Takayuki Sumida, Yoshiya Tanaka, Tsuneyo Mimori, Tsutomu Chiba, Michiaki Mishima, Toshifumi Hibi, Hirohito Tsubouchi, Kazuo Inui, Hirotaka Ohara.   

Abstract

BACKGROUND: IgG4-related disease (IgG4-RD) is a novel clinical disease entity characterized by elevated serum IgG4 concentration and tumefaction or tissue infiltration by IgG4+ plasma cells. Although IgG4-RD is not rare and is clinically important, its clinical diagnostic criteria have not been established. Comprehensive diagnostic criteria for IgG4-RD, including the involvement of various organs, are intended for the practical use of general physicians and nonspecialists.
METHODS: Two IgG4-RD study groups, the Umehara and Okazaki teams, were organized by the Ministry of Health, Labor and Welfare Japan. As IgG4-RD comprises a wide variety of diseases, these groups consist of physicians and researchers in various disciplines, including rheumatology, hematology, gastroenterology, nephrology, pulmonology, ophthalmology, odontology, pathology, statistics, and basic and molecular immunology throughout Japan, with 66 and 56 members of the Umehara and Okazaki teams, respectively. Collaborations of the two study groups involved detailed analyses of clinical symptoms, laboratory results, and biopsy specimens of patients with IgG4-RD, resulting in the establishment of comprehensive diagnostic criteria for IgG4-RD.
RESULTS: Although many patients with IgG4-RD have lesions in several organs, either synchronously or metachronously, and the pathological features of each organ differ, consensus has been reached on two diagnostic criteria for IgG4RD: (1) serum IgG4 concentration >135 mg/dl, and (2) >40% of IgG+ plasma cells being IgG4+ and >10 cells/high powered field of biopsy sample. Although the comprehensive diagnostic criteria are not sufficiently sensitive for the diagnosis of type 1 IgG4-related autoimmune pancreatitis (IgG4-related AIP), they are adequately sensitive for IgG4-related Mikulicz's disease (MD) and kidney disease (KD). In addition, the comprehensive diagnostic criteria, combined with organ-specific diagnostic criteria, have increased the sensitivity of diagnosis to 100% for IgG4-related MD, KD, and AIP.
CONCLUSION: Our comprehensive diagnostic criteria for IgG4-RD are practically useful for general physicians and nonspecialists.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22218969     DOI: 10.1007/s10165-011-0571-z

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  491 in total

Review 1.  IgG4-related disease: what urologists should know.

Authors:  Daniele Bianchi
Journal:  Int Urol Nephrol       Date:  2016-01-02       Impact factor: 2.370

2.  Characterization and Comparison of Patient Subgroups Suspicious for IgG4-Related Disease and Malignant Lymphoma in Patients Followed-up for Sjögren's Syndrome.

Authors:  Antónia Szántó; Katalin Szabó; Gábor Nagy; Csaba Molnár; Margit Zeher
Journal:  Pathol Oncol Res       Date:  2016-01-19       Impact factor: 3.201

3.  International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease.

Authors:  David C Fajgenbaum; Thomas S Uldrick; Adam Bagg; Dale Frank; David Wu; Gordan Srkalovic; David Simpson; Amy Y Liu; David Menke; Shanmuganathan Chandrakasan; Mary Jo Lechowicz; Raymond S M Wong; Sheila Pierson; Michele Paessler; Jean-François Rossi; Makoto Ide; Jason Ruth; Michael Croglio; Alexander Suarez; Vera Krymskaya; Amy Chadburn; Gisele Colleoni; Sunita Nasta; Raj Jayanthan; Christopher S Nabel; Corey Casper; Angela Dispenzieri; Alexander Fosså; Dermot Kelleher; Razelle Kurzrock; Peter Voorhees; Ahmet Dogan; Kazuyuki Yoshizaki; Frits van Rhee; Eric Oksenhendler; Elaine S Jaffe; Kojo S J Elenitoba-Johnson; Megan S Lim
Journal:  Blood       Date:  2017-01-13       Impact factor: 22.113

Review 4.  Clinical and pathophysiological issues associated with type 1 autoimmune pancreatitis.

Authors:  Kazushige Uchida; Hideaki Miyoshi; Tsukasa Ikeura; Masaaki Shimatani; Makoto Takaoka; Kazuichi Okazaki
Journal:  Clin J Gastroenterol       Date:  2016-02-10

5.  IgG4-related disease mimicking chalazion in the upper eyelid with skin manifestations on the trunk.

Authors:  Tiina Leivo; Sari Koskenmies; Marita Uusitalo; Olli Tynninen
Journal:  Int Ophthalmol       Date:  2015-04-03       Impact factor: 2.031

Review 6.  Retroperitoneal fibrosis associated with immunoglobulin G4-related disease.

Authors:  Nao Fujimori; Tetsuhide Ito; Hisato Igarashi; Takamasa Oono; Taichi Nakamura; Yusuke Niina; Masayuki Hijioka; Lingaku Lee; Masahiko Uchida; Ryoichi Takayanagi
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

7.  Recurrent severe acute hepatitis caused by hypereosinophilic syndrome associated with elevated serum immunoglobulin G4 levels.

Authors:  Tomonori Aoyama; Toshiharu Matsumoto; Akira Uchiyama; Kazuyoshi Kon; Shunhei Yamashina; Satoko Suzuki; Kenichi Ikejima; Takashi Yao; Ryohei Kuwatsuru; Sumio Watanabe
Journal:  Clin J Gastroenterol       Date:  2014-10-16

8.  IgG4-Related Systemic Disease Can Be Easily Mistaken as a Uroepithelial Tumor.

Authors:  Song Yi Han; Seung Ik Lee; Yeon Hee Lee; Ae Jin Kim; Hye Jin Lim; Han Ro; Jae Hyun Chang; Hyun Hee Lee; Wookyung Chung; Ji Yong Jung
Journal:  Chonnam Med J       Date:  2015-04-14

Review 9.  Endoscopic retrograde cholangiopancreatography and intraductal ultrasonography in the diagnosis of autoimmune pancreatitis and IgG4-related sclerosing cholangitis.

Authors:  Itaru Naitoh; Takahiro Nakazawa
Journal:  J Med Ultrason (2001)       Date:  2021-07-31       Impact factor: 1.314

Review 10.  [IgG4-related disease].

Authors:  J Loock; B Manger
Journal:  Z Rheumatol       Date:  2013-03       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.